151 related articles for article (PubMed ID: 34169610)
1. Risk of anticholinergic burden in adults with intellectual disabilities: a Scottish retrospective cohort study of n = 17 220.
Ward LM; Stanley B; Greenlaw N; Cooper SA; Pacitti C; Henderson A; Gibson J; Kinnear D
J Intellect Disabil Res; 2021 Sep; 65(9):813-830. PubMed ID: 34169610
[TBL] [Abstract][Full Text] [Related]
2. A study on prescriptions contributing to the risk of high anticholinergic burden in adults with intellectual disabilities: retrospective record linkage study.
Laura Ward M; Cooper SA; Henderson A; Stanley B; Greenlaw N; Pacitti C; Cairns D
Ann Gen Psychiatry; 2022 Oct; 21(1):41. PubMed ID: 36309752
[TBL] [Abstract][Full Text] [Related]
3. Multiple physical and mental health comorbidity in adults with intellectual disabilities: population-based cross-sectional analysis.
Cooper SA; McLean G; Guthrie B; McConnachie A; Mercer S; Sullivan F; Morrison J
BMC Fam Pract; 2015 Aug; 16():110. PubMed ID: 26310664
[TBL] [Abstract][Full Text] [Related]
4. Medication burden and frailty in older adults with intellectual disability: An observational cross-sectional study.
O'Connell J; Henman MC; McMahon N; Burke É; McCallion P; McCarron M; O'Dwyer M
Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):482-492. PubMed ID: 32134549
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergic burden in adult and elderly people with intellectual disabilities: Results from an Italian multicenter cross-sectional study.
De Vreese LP; Mantesso U; De Bastiani E; Marangoni A; Weger E; Gomiero T
PLoS One; 2018; 13(10):e0205897. PubMed ID: 30379948
[TBL] [Abstract][Full Text] [Related]
6. Association of Drug Burden Index with grip strength, timed up and go and Barthel index activities of daily living in older adults with intellectual disabilities: an observational cross-sectional study.
O'Connell J; Henman MC; Burke É; Donegan C; McCallion P; McCarron M; O'Dwyer M
BMC Geriatr; 2019 Jun; 19(1):173. PubMed ID: 31234775
[TBL] [Abstract][Full Text] [Related]
7. Association of anticholinergic burden with adverse effects in older people with intellectual disabilities: an observational cross-sectional study.
O'Dwyer M; Maidment ID; Bennett K; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
Br J Psychiatry; 2016 Dec; 209(6):504-510. PubMed ID: 27660331
[TBL] [Abstract][Full Text] [Related]
8. Drug burden index to define the burden of medicines in older adults with intellectual disabilities: An observational cross-sectional study.
O'Connell J; Burke É; Mulryan N; O'Dwyer C; Donegan C; McCallion P; McCarron M; Henman MC; O'Dwyer M
Br J Clin Pharmacol; 2018 Mar; 84(3):553-567. PubMed ID: 29193284
[TBL] [Abstract][Full Text] [Related]
9. Prescription of potentially inappropriate medications among older people with intellectual disability: a register study.
Axmon A; Sandberg M; Ahlström G; Midlöv P
BMC Pharmacol Toxicol; 2017 Oct; 18(1):68. PubMed ID: 29070067
[TBL] [Abstract][Full Text] [Related]
10. Disentangling drug contributions: anticholinergic burden in older adults linked to individual medications: a cross-sectional population-based study.
Bhatkhande G; Choudhry NK; Mahesri M; Haff N; Lauffenburger JC
BMC Geriatr; 2024 Jan; 24(1):44. PubMed ID: 38200457
[TBL] [Abstract][Full Text] [Related]
11. Dental attendance, restoration and extractions in adults with intellectual disabilities compared with the general population: a record linkage study.
Ward LM; Cooper SA; McSkimming P; Greenlaw N; Pacitti C; Gibson J; Henderson A; Stanley B; Pell J; Kinnear D
J Intellect Disabil Res; 2020 Dec; 64(12):980-986. PubMed ID: 32996662
[TBL] [Abstract][Full Text] [Related]
12. Relation Between Delirium and Anticholinergic Drug Burden in a Cohort of Hospitalized Older Patients: An Observational Study.
Pasina L; Colzani L; Cortesi L; Tettamanti M; Zambon A; Nobili A; Mazzone A; Mazzola P; Annoni G; Bellelli G
Drugs Aging; 2019 Jan; 36(1):85-91. PubMed ID: 30484239
[TBL] [Abstract][Full Text] [Related]
13. The extent of anticholinergic burden across an older Welsh population living with frailty: cross-sectional analysis of general practice records.
Cheong VL; Mehdizadeh D; Todd OM; Gardner P; Zaman H; Clegg A; Alldred DP; Faisal M
Age Ageing; 2023 Jul; 52(7):. PubMed ID: 37505992
[TBL] [Abstract][Full Text] [Related]
14. Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data.
Niznik J; Zhao X; Jiang T; Hanlon JT; Aspinall SL; Thorpe J; Thorpe C
Drugs Aging; 2017 Dec; 34(12):925-939. PubMed ID: 29214512
[TBL] [Abstract][Full Text] [Related]
15. The relationship between physical ill-health and mental ill-health in adults with intellectual disabilities.
Dunham A; Kinnear D; Allan L; Smiley E; Cooper SA
J Intellect Disabil Res; 2018 May; 62(5):444-453. PubMed ID: 29532540
[TBL] [Abstract][Full Text] [Related]
16. Adverse Effects of Anticholinergic Drugs on Cognition and Mobility: Cutoff for Impairment in a Cross-Sectional Study in Young-Old and Old-Old Adults.
Attoh-Mensah E; Loggia G; Schumann-Bard P; Morello R; Descatoire P; Marcelli C; Chavoix C
Drugs Aging; 2020 Apr; 37(4):301-310. PubMed ID: 31930459
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of people with intellectual disability admitted to hospital with constipation: identifying possible specific high-risk factors.
Laugharne R; Wilcock M; Rees J; Wainwright D; Newton N; Sterritt J; Badger S; Bishop R; Bassett P; Shankar R
J Intellect Disabil Res; 2024 Mar; 68(3):277-284. PubMed ID: 38031737
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergic and sedative medications exposure in older patients: a cross-sectional study.
Zhang X; Zhou S; Li X; Zhou W; Zhou Y; Cui Y; Liu X
Int J Clin Pharm; 2019 Oct; 41(5):1152-1158. PubMed ID: 31392583
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of factors associated with edentulousness (no natural teeth) in adults with intellectual disabilities.
Kinnear D; Allan L; Morrison J; Finlayson J; Sherriff A; Macpherson L; Henderson A; Ward L; Muir M; Cooper SA
J Intellect Disabil Res; 2019 Dec; 63(12):1475-1481. PubMed ID: 31062460
[TBL] [Abstract][Full Text] [Related]
20. Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease.
Crispo JA; Willis AW; Thibault DP; Fortin Y; Hays HD; McNair DS; Bjerre LM; Kohen DE; Perez-Lloret S; Mattison DR; Krewski D
PLoS One; 2016; 11(3):e0150621. PubMed ID: 26939130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
